PM
LEGN icon

Parametrica Management’s Legend Biotech LEGN Stock Holding History

Parametrica Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,800
Closed -$662K – 27
2024
Q1 		$662K Hold
11,800
– – 0.95% 20
2023
Q4 		$710K Buy
+11,800
New +$748K 1.17% 23
2022
Q2 		– Sell
-6,064
Closed -$220K – 254
2022
Q1 		$220K Buy
+6,064
New +$240K 0.16% 182

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Parametrica Management's LEGN Position: Q2 2024 in Review

Parametrica Management sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 11,800 shares — an estimated $662K sold.

Parametrica Management first reported a position in LEGN in Q1 2022 and held it in 3 quarters. The position peaked at $710K in Q4 2023. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.

  • Parametrica Management reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
  • Parametrica Management sold 11,800 Legend Biotech shares in Q2 2024, an estimated $662K.
  • Parametrica Management first reported a position in Legend Biotech in Q1 2022 and held it in 3 quarters.
  • Parametrica Management's Legend Biotech position peaked at $710K in Q4 2023.
  • 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.

Based on Parametrica Management's 13F filing for Q2 2024, filed 8 Aug 2024.